James Kihara is PRINCIPAL ACCOUNTING OFFICER of ACADIA PHARMACEUTICALS INC. Currently has a direct ownership of 20,395 shares of ACAD, which is worth approximately $435,229. The most recent transaction as insider was on Apr 10, 2023, when has been sold 523 shares (Common Stock) at a price of $18.14 per share, resulting in proceeds of $9,487. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 20.4K
0.83% 3M change
41.93% 12M change
Total Value Held $435,229

James Kihara Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 10 2023
SELL
Open market or private sale
$9,487 $18.14 p/Share
523 Reduced 9.14%
5,197 Common Stock
Apr 07 2023
BUY
Exercise of conversion of derivative security
-
1,489 Added 20.65%
5,720 Common Stock
Apr 06 2023
SELL
Open market or private sale
$12,730 $18.16 p/Share
701 Reduced 14.21%
4,231 Common Stock
Apr 05 2023
BUY
Exercise of conversion of derivative security
-
2,009 Added 28.94%
4,932 Common Stock
Feb 24 2023
SELL
Open market or private sale
$6,573 $18.78 p/Share
350 Reduced 10.69%
2,923 Common Stock
Feb 23 2023
BUY
Exercise of conversion of derivative security
-
840 Added 20.42%
3,273 Common Stock
Apr 08 2022
SELL
Open market or private sale
$27,726 $27.05 p/Share
1,025 Reduced 29.64%
2,433 Common Stock
Apr 07 2022
BUY
Exercise of conversion of derivative security
-
2,977 Added 46.26%
3,458 Common Stock
Feb 23 2022
SELL
Open market or private sale
$8,544 $23.8 p/Share
359 Reduced 42.74%
481 Common Stock
Feb 23 2022
BUY
Exercise of conversion of derivative security
-
840 Added 50.0%
840 Common Stock
JK

James Kihara

PRINCIPAL ACCOUNTING OFFICER
San Diego, CA

Track Institutional and Insider Activities on ACAD

Follow ACADIA PHARMACEUTICALS INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells ACAD shares.

Notify only if

Insider Trading

Get notified when an Acadia Pharmaceuticals Inc insider buys or sells ACAD shares.

Notify only if

News

Receive news related to ACADIA PHARMACEUTICALS INC

Track Activities on ACAD